What does InMed Pharmaceuticals, Inc. do?

Jun 22 2025 06:44 PM IST
share
Share Via
InMed Pharmaceuticals, Inc. is a pre-clinical-stage biopharmaceutical company focused on developing cannabinoid-based therapies. As of March 2025, it has a market cap of $2.85 million, with net sales of $1 million and a net loss of $2 million.
Overview:
InMed Pharmaceuticals, Inc. is a pre-clinical-stage biopharmaceutical company specializing in the research and development of cannabinoid-based therapies within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025)
Market-cap: USD 2.85 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.61
Return on Equity: -118.37%
Price to Book: 0.41

Contact Details:
Address: SUITE 310, 815 W. HASTINGS STREET, VANCOUVER BC : V6C 1B4
Tel: 1 604 6697207
Website: https://www.inmedpharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is InMed Pharmaceuticals, Inc. overvalued or undervalued?
Sep 20 2025 06:21 PM IST
share
Share Via
Is InMed Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 08:59 AM IST
share
Share Via
How big is InMed Pharmaceuticals, Inc.?
Jun 22 2025 06:02 PM IST
share
Share Via